Eleven-Year Summary of Selected Consolidated Financial Data
Walgreen Co. and Subsidiaries
(Dollars in Millions, except per share amounts)
 
Fiscal Year
 
2006
 
2005
 
2004
 
2003
 
Net Sales
 
$
47,409.0
 
$
42,201.6
 
$
37,508.2
 
$
32,505.4
 
Costs and Deductions
                         
Cost of sales
   
34,240.4
   
30,413.8
   
27,310.4
   
23,706.2
 
Selling, occupancy and administration (1)
   
10,467.1
   
9,363.8
   
8,055.4
   
6,938.3
 
Other income (2)
   
52.6
   
31.6
   
17.3
   
10.8
 
Total Costs and Deductions
   
44,654.9
   
39,746.0
   
35,348.5
   
30,633.7
 
Earnings
                         
Earnings before income tax provision and cumulative effect of accounting changes
   
2,754.1
   
2,455.6
   
2,159.7
   
1,871.7
 
Income tax provision
   
1,003.5
   
896.1
   
809.9
   
706.6
 
Earnings before cumulative effect of accounting changes
   
1,750.6
   
1,559.5
   
1,349.8
   
1,165.1
 
Cumulative effect of accounting changes (3)
   
-
   
-
   
-
   
-
 
Net Earnings
 
$
1,750.6
 
$
1,559.5
 
$
1,349.8
 
$
1,165.1
 
Per Common Share (4)
                         
Net earnings (3)
                         
Basic
 
$
1.73
 
$
1.53
 
$
1.32
 
$
1.14
 
Diluted
   
1.72
   
1.52
   
1.31
   
1.13
 
Dividends declared
   
.27
   
.22
   
.18
   
.16
 
Book value
   
10.04
   
8.77
   
7.95
   
6.94
 
Non-Current Liabilities
                         
Long-term debt
 
$
3.2
 
$
12.0
 
$
12.4
 
$
9.4
 
Deferred income taxes
   
141.1
   
240.4
   
274.1
   
180.7
 
Other non-current liabilities
   
1,115.7
   
985.7
   
838.0
   
677.5
 
Assets and Equity
                         
Total assets
 
$
17,131.1
 
$
14,608.8
 
$
13,342.1
 
$
11,656.8
 
Shareholders' equity
   
10,115.8
   
8,889.7
   
8,139.7
   
7,117.8
 
Return on average shareholders' equity
   
18.4
%
 
18.3
%
 
17.7
%
 
17.5
%
Drugstore Units
                         
Year-end: Units (5)
   
5,461
   
4,985
   
4,613
   
4,252
 

 

-1-

   
2002
 
2001
 
2000
 
1999
 
1998
 
1997
 
1996
     
$
28,681.1
 
$
24,623.0
 
$
21,206.9
 
$
17,838.8
 
$
15,306.6
 
$
13,363.0
 
$
11,778.4
                                                     
21,076.1
   
18,048.9
   
15,465.9
   
12,978.6
   
11,139.4
   
9,681.8
   
8,514.9
       
5,992.5
   
5,171.0
   
4,501.2
   
3,859.6
   
3,341.6
   
2,979.6
   
2,666.1
       
6.9
   
2.3
   
5.7
   
11.9
   
41.9
   
3.9
   
2.9
       
27,061.7
   
23,217.6
   
19,961.4
   
16,826.3
   
14,439.1
   
12,657.5
   
11,178.1
                                                                               
                   
1,619.4
   
1,405.4
   
1,245.5
   
1,012.5
   
867.5
   
705.5
   
600.3
       
611.3
   
530.6
   
479.5
   
397.4
   
336.2
   
273.4
   
232.6
       
1,008.1
   
874.8
   
766.0
   
615.1
   
531.3
   
432.1
   
367.7
 
 
    -     
-
   
-
   
-
   
(26.4
)
 
-
   
-
     
$
1,008.1
 
$
874.8
 
$
766.0
 
$
615.1
 
$
504.9
 
$
432.1
 
$
367.7
                                                                               
                 
$
.99
 
$
.86
 
$
.76
 
$
.61
 
$
.50
 
$
.43
 
$
.38
       
.98
   
.85
   
.75
   
.61
   
.50
   
.43
   
.37
       
.15
   
.14
   
.14
   
.13
   
.13
   
.12
   
.11
       
6.01
   
5.05
   
4.14
   
3.44
   
2.83
   
2.38
   
2.06
                                                   
$
11.2
 
$
20.8
 
$
18.2
 
$
18.0
 
$
13.6
 
$
3.3
 
$
3.4
       
135.6
   
102.9
   
74.0
   
54.1
   
74.2
   
101.6
   
136.7
       
613.9
   
547.5
   
519.2
   
461.0
   
410.3
   
310.0
   
283.6
                                                   
$
10,117.2
 
$
9,042.3
 
$
7,103.7
 
$
5,906.7
 
$
4,901.6
 
$
4,207.1
 
$
3,633.6
       
6,162.9
   
5,151.0
   
4,188.6
   
3,449.8
   
2,823.4
   
2,353.7
   
2,027.9
       
17.8
%
 
18.7
%
 
20.1
%
 
19.6
%
 
19.5
%
 
19.7
%
 
19.3
%
                                                   
3,899
   
3,536
   
3,181
   
2,830
   
2,556
   
2,366
   
2,199
 

 
(1)
Fiscal 2006 includes a $12.3 million ($.008 per share, diluted) downward
adjustment of the fiscal 2005 pre-tax expenses of $54.7 million ($.033 per
share, diluted) related to Hurricane Katrina. Fiscal 2006, 2005, 2004, 2003,
2002, 2001 and 2000 include pre-tax income of $7.3 million ($.005 per share,
diluted), $26.3 million ($.016 per share, diluted), $16.3 million ($.010 per
share, diluted), $29.6 million ($.018 per share, diluted), $6.2 million ($.004
per share, diluted), $22.1 million ($.013 per share, diluted) and $33.5 million
($.021 per share, diluted), respectively, from litigation settlements.

(2)
Fiscal 1998 includes a pre-tax gain of $37.4 million ($.023 per share, diluted)
from the sale of the company's long-term care pharmacy business.

(3)
Fiscal 1998 includes an after-tax $26.4 million ($.026 per share, diluted)
charge from the cumulative effect of accounting change for system development
costs.

(4)
Per share amounts have been adjusted for two-for-one stock splits in 1999 and
1997.

(5)
Units include stores, mail service facilities, home care facilities, clinic
pharmacies and specialty pharmacies.

 
 
 

-2-

MANAGEMENT'S DISCUSSION AND ANALYSIS
OF RESULTS OF OPERATIONS AND FINANCIAL CONDITION

Introduction

Walgreens is a retail drugstore chain that sells prescription and
non-prescription drugs and general merchandise. General merchandise includes,
among other things, beauty care, personal care, household items, candy,
photofinishing, greeting cards, seasonal items and convenience food. Customers
can have prescriptions filled at the drugstore counter, as well as through the
mail, by telephone and on the Internet. As of August 31, 2006, we operated 5,461
stores (including three mail service facilities, 38 home care facilities, 18
clinic pharmacies and five specialty pharmacies) located in 47 states and Puerto
Rico.

The drugstore industry is highly competitive. In addition to other drugstore
chains, independent drugstores and mail order prescription providers, we also
compete with various other retailers including grocery stores, convenience
stores, mass merchants and dollar stores.

Prescription sales continue to become a larger portion of the company's
business. The long-term outlook for prescription sales is strong due in part to
the aging population, the introduction of lower priced generics and the
continued development of innovative drugs that improve quality of life and
control healthcare costs. As of January 1, 2006, the Medicare Part D
prescription drug program went into effect. This program has resulted in
additional prescription sales, although the gross margin rates on these sales
have been lower. The Deficit Reduction Act of 2005 becomes effective during
fiscal 2007, and is expected to reduce our reimbursement for Medicaid generic
drugs.

Front-end sales have continued to grow due to strengthening core categories and
new businesses such as digital photo services and the introduction of our new
inkjet printer cartridge refill program. Walgreen private brand sales now
comprise 17% of front-end sales.

We continue to expand into new markets and increase penetration in existing
markets. To support our growth, we are investing significantly in prime
locations, technology and customer service initiatives. Organic growth continues
to be our primary growth vehicle; however, consideration is given to
acquisitions that provide a unique opportunity and strategic fit. In fiscal
2006, for example, we merged with Happy Harry's, a drugstore chain with 76
locations, primarily in Delaware. Our managed care division continues to grow
organically, as well as through acquisitions. Three recent acquisitions include
Schraft's A Specialty Pharmacy, for infertility drugs; Medmark Inc., a specialty
pharmacy business; and SeniorMed LLC, which supplies medications to assisted
living and long-term care institutions.

Operating Statistics

   
Percentage Increases
 
Fiscal Year
 
2006
 
2005
 
2004
 
Net Sales
   
12.3
   
12.5
   
15.4
 
Net Earnings
   
12.3
   
15.5
   
15.9
 
Comparable Drugstore Sales
   
7.7
   
8.2
   
10.9
 
Prescription Sales
   
13.3
   
13.4
   
17.8
 
Comparable Drugstore Prescription Sales
   
9.2
   
9.8
   
14.0
 
Front-End Sales
   
10.9
   
11.1
   
11.7
 
Comparable Front-End Sales
   
5.3
   
5.5
   
6.1
 

 

-3-

   
Percent to Sales
 
Fiscal Year
   
2006
   
2005
   
2004
 
Gross Margin
   
27.8
   
27.9
   
27.2
 
Selling, Occupancy and Administration Expenses
   
22.1
   
22.2
   
21.5
 

   
Other Statistics
 
Fiscal Year
   
2006
   
2005
   
2004
 
Prescription Sales as a % of Net Sales
   
64.3
   
63.7
   
63.2
 
Third Party Sales as a % of Drugstore Prescription Sales
   
93.1
   
92.7
   
91.7
 
Total Number of Stores (1)
   
5,461
   
4,985
   
4,613
 
 
(1) The total number of stores for fiscal years 2005 and 2004 have been adjusted
to include home care locations for consistency.

Results of Operations

Fiscal 2006 was our 32nd consecutive year of record sales and earnings. Fiscal
year net earnings increased 12.3% to $1.751 billion, or $1.72 per share
(diluted), versus last year's earnings of $1.560 billion, or $1.52 per share
(diluted). Net earnings increases resulted from improved sales with lower
expense ratios, partially offset by lower gross profit margins.

This year's results included a $102.5 million pre-tax or $.06 per share
(diluted) charge related to the first quarter adoption of Statement of Financial
Accounting Standards (SFAS) No. 123(R), "Share-Based Payments," which requires
expensing stock options based on the fair value of those options at the date of
the grant. In the fourth quarter of fiscal year 2005, the company recorded $54.7
million ($.03 per share, diluted) of pre-tax expenses related to Hurricane
Katrina, which hit the Gulf Coast area in late August. These estimates were
revised downward by $12.3 million in fiscal year 2006. Fiscal 2006 also included
pre-tax litigation settlement gains of $7.3 million (less than $.01 per share,
diluted) compared to similar settlements of $26.3 million ($.02 per share,
diluted) in fiscal 2005 and $16.3 million ($.01 per share, diluted) in fiscal
2004.

Net sales increased by 12.3% to $47.409 billion in fiscal 2006 compared to
increases of 12.5% in 2005 and 15.4% in 2004. Drugstore sales increases resulted
from sales gains in existing stores and added sales from new stores, each of
which includes an indeterminate amount of market-driven price changes. Sales in
comparable drugstores were up 7.7% in 2006, 8.2% in 2005 and 10.9% in 2004.
Comparable drugstores are defined as those that have been open for at least
twelve consecutive months without closure for seven or more consecutive days and
without a major remodel or a natural disaster in the past twelve months.
Relocated stores are not included as comparable stores for the first twelve
months after the relocation. The company operated 5,461 stores at August 31,
2006, compared to 4,985 at August 31, 2005 and 4,613 at August 31, 2004.

Prescription sales increased 13.3% in 2006, 13.4% in 2005 and 17.8% in 2004.
Comparable drugstore prescription sales were up 9.2% in 2006, 9.8% in 2005 and
14.0% in 2004. Prescription sales were 64.3% of total net sales for fiscal 2006
compared to 63.7% in 2005 and 63.2% in 2004. The effect of generic drugs, which
have a lower retail price, replacing brand name drugs reduced prescription sales
by 2.0% for 2006, 2.4% for 2005 and 1.2% for 2004. Third party sales, where
reimbursement is received from managed care organizations as well as government
and private insurance, were 93.1% of pharmacy sales in 2006, 92.7% in 2005 and
91.7% in 2004. The total number of prescriptions filled for fiscal 2006 was
approximately 529 million; 489 million in fiscal 2005 and 442 million in fiscal
2004.

Front-end sales increased 10.9% in 2006, 11.1% in 2005 and 11.7% in 2004.
Front-end sales were 35.6% of total sales in fiscal 2006, 36.1% in 2005 and
36.5% in 2004. Comparable front-end sales increased 5.3% in 2006, 5.5% in 2005
and 6.1% in 2004.

 

-4-

Gross margins as a percent of total net sales were 27.8% in 2006, 27.9% in 2005
and 27.2% in 2004. The growth in the Walgreens Health Services portion of the
business, with lower gross margins than drugstores, negatively affected gross
profit percents. Pharmacy margins decreased, in part, due to lower gross margin
on Medicare Part D prescription sales. This was largely offset by higher generic
drug utilization, which was aided by the steady stream of new generics over the
past year. The continuing shift in sales mix toward prescriptions, which carry a
lower margin than front-end merchandise, and growth in third party sales, which
typically have lower profit margins than cash prescriptions, continue to
adversely affect gross profit margins. Front-end margins were slightly higher
for the year.

We use the last-in, first-out (LIFO) method of inventory valuation. The LIFO
provision is dependent upon inventory levels, inflation rates and merchandise
mix. The effective LIFO inflation rates were 1.53% in 2006, 1.26% in 2005 and
.14% in 2004, which resulted in charges to cost of sales of $95.3 million in
2006, $67.8 million in 2005 and $6.7 million in 2004. Inflation on prescription
inventory was 2.37% in 2006, 2.18% in 2005 and .72% in 2004. In all three fiscal
years, we experienced deflation in some non-prescription inventories.

Selling, occupancy and administration expenses were 22.1% of sales in fiscal
2006, 22.2% in fiscal 2005 and 21.5% in fiscal 2004. The decrease in fiscal 2006
resulted from a $12.3 million adjustment lowering last fiscal year's $54.7
million pre-tax expense associated with Hurricane Katrina. Also affecting the
fiscal 2006 decrease were lower costs incurred as a result of the conversion
from analog to digital photo labs. These decreases were partially offset by the
fiscal 2006 adoption of SFAS No. 123(R), which requires the expensing of stock
options. Fiscal 2005 was also affected by higher store salaries. Lower sales as
a result of new generic drugs also increased expense ratios during the periods.

Interest income increased in 2006 due to higher interest rates. Average net
investment levels were approximately $1.225 billion in 2006, $1.307 billion in
2005 and $1.281 billion in 2004.

The effective income tax rate was 36.4% for fiscal 2006, 36.5% for 2005 and
37.5% for 2004. Both fiscal 2006 and fiscal 2005 rates were affected, in part,
by the settlement of prior years' Internal Revenue Service matters. All tax
years prior to fiscal 2004 have been finalized with the Internal Revenue
Service. Fiscal 2005 was also affected by foreign tax credit adjustments.

Critical Accounting Policies

The consolidated financial statements are prepared in accordance with accounting
principles generally accepted in the United States of America and include
amounts based on management's prudent judgments and estimates. Actual results
may differ from these estimates. Management believes that any reasonable
deviation from those judgments and estimates would not have a material impact on
our consolidated financial position or results of operations. To the extent that
the estimates used differ from actual results, however, adjustments to the
statement of earnings and corresponding balance sheet accounts would be
necessary. These adjustments would be made in future statements. Some of the
more significant estimates include liability for closed locations, liability for
insurance claims, vendor allowances, allowance for doubtful accounts and cost of
sales. We use the following techniques to determine our estimates:

Liability for closed locations -
The liability is based on the present value of future rent obligations and other
related costs (net of estimated sublease rent) to the first lease option date.
We have not made any material changes to the method of estimating our liability
for closed locations during the last three years. Based on current knowledge, we
do not believe there is a reasonable likelihood that there will be a material
change in the estimate or assumptions used to determine the liability.

 

-5-

Liability for insurance claims -
The liability for insurance claims is recorded based on estimates for claims
incurred. The provisions are estimated in part by considering historical claims
experience, demographic factors and other actuarial assumptions. We have not
made any material changes to the method of estimating our liability for
insurance claims during the last three years. Based on current knowledge, we do
not believe there is a reasonable likelihood that there will be a material
change in the estimate or assumptions used to determine the liability.
Vendor allowances -
Vendor allowances are principally received as a result of purchase levels, sales
or promotion of vendors' products. Allowances are generally recorded as a
reduction of inventory and are recognized as a reduction of cost of sales when
the related merchandise is sold. Those allowances received for promoting
vendors' products are offset against advertising expense and result in a
reduction of selling, occupancy and administration expense to the extent of
advertising incurred, with the excess treated as a reduction of inventory costs.
We have not made any material changes to the method of estimating our vendor
allowances during the last three years. Based on current knowledge, we do not
believe there is a reasonable likelihood that there will be a material change in
the estimate or assumptions used to determine vendor allowances.
Allowance for doubtful accounts -
The provision for bad debt is based on both specific receivables and historic
write-off percentages. We have not made any material changes to the method of
estimating our allowance for doubtful accounts during the last three years.
Based on current knowledge, we do not believe there is a reasonable likelihood
that there will be a material change in the estimate or assumptions used to
determine the allowance.
Cost of sales -
Drugstore cost of sales is primarily derived based on point-of-sale scanning
information with an estimate for shrinkage and adjusted based on periodic
inventories. We have not made any material changes to the method of estimating
cost of sales during the last three years. Based on current knowledge, we do not
believe there is a reasonable likelihood that there will be a material change in
the estimate or assumptions used to determine cost of sales.

Liquidity and Capital Resources

Cash and cash equivalents were $919.9 million at August 31, 2006, compared to
$576.8 million at August 31, 2005. Short-term investment objectives are to
minimize risk, maintain liquidity and maximize after-tax yields. To attain these
objectives, investment limits are placed on the amount, type and issuer of
securities. Investments are principally in top-tier money market funds and
commercial paper.

Net cash provided by operating activities was $2.440 billion in fiscal 2006 and
$1.371 billion in fiscal 2005. The change between periods was primarily caused
by increased net earnings and better inventory control. The increase in accounts
receivable, as well as the increase in trade accounts payable, were both driven
by growth in our pharmacy benefit management business under the Medicare Part D
prescription plan. Our profitability is the principal source of funds for
expansion, acquisitions, remodeling programs, dividends to shareholders and the
stock repurchase program.

Net cash used for investing activities was $1.684 billion versus $434.0 million
last year. Proceeds from the sale of auction rate securities exceeded purchases
of such securities by $106.0 million in fiscal 2006 compared to $777.9 million
in fiscal 2005. We actively invest in municipal bonds and student obligations
and purchase these securities at par. While the underlying security is issued as
a long-term investment, they typically can be purchased and sold every 7, 28 and
35 days. The trading of auction rate securities takes place through a descending
price auction with the interest rate reset at the beginning of each holding
period. At the end of each holding period the interest is paid to the investor.

 

-6-

Additions to property and equipment were $1.338 billion compared to $1.238
billion last year. In total there were 570 new or relocated locations (net 476)
in fiscal 2006. This compared to 440 last year (net 372). New stores are owned
or leased. There were 136 owned locations added during the year and 62 under
construction at August 31, 2006, versus 103 owned locations added and 96 under
construction as of August 31, 2005. Business acquisitions include Schraft's A
Specialty Pharmacy, which provides fertility medications and services; Medmark
Inc., which provides pharmacy care to patients with unique or chronic medication
needs; SeniorMed LLC, an institutional pharmacy, which provides prescription
services to assisted living communities; Home Pharmacy of California and
Canadian Valley Medical Solutions, which provide home care services; and
selected assets from the 23-store Medic drugstore chain in the Cleveland market.
A merger with Delaware-based Happy Harry's pharmacy chain included all 76 Happy
Harry's stores in Delaware, Pennsylvania, Maryland and New Jersey, along with
the corporate office and distribution center in Newark, Delaware.

Capital expenditures for fiscal 2007 are expected to be approximately $1.7
billion, excluding business acquisitions. We expect to open approximately 500
new stores in fiscal 2007, with a net increase of more than 400 stores, and
anticipate having a total of 7,000 stores by the year 2010. We are continuing to
relocate stores to more convenient and profitable freestanding locations. In
addition to new stores, expenditures are planned for distribution centers and
technology. Two new distribution centers are scheduled: one in Anderson, South
Carolina, with an anticipated opening date in fiscal 2007 and another in
Windsor, Connecticut, with an anticipated opening date in fiscal 2009.

Net cash used for financing activities was $413.0 million compared to $804.4
million last year. On July 14, 2004, the Board of Directors announced a stock
repurchase program of up to $1 billion, which we plan to execute over four
years. During fiscal 2006 we purchased $289.7 million of company shares related
to the stock repurchase program for a total of $656.8 million in purchases since
the start of the program. An additional $379.1 million of shares were purchased
to support the long-term needs of the employee stock plans. Comparable amounts
were $345.1 million and $436.7 million in fiscal 2005. Cash dividends paid were
$262.9 million for fiscal 2006 versus $214.5 million last year. A $213.9 million
wire transfer made on August 31, 2006, was not accepted by our disbursement bank
until September 1, resulting in a bank overdraft at fiscal year-end. There were
no new short-term borrowings during either period. At August 31, 2006, we had a
syndicated bank line of credit facility of $200 million to support our
short-term commercial paper program.

Our credit ratings as of August 31, 2006, were as follows:
Rating Agency
Rating
Outlook
Moody's
Aa3
Negative
Standard & Poor's
A+
Stable

 
In assessing our credit strength, both Moody's and Standard & Poor's consider
our business model, capital structure, financial policies and financial
statements. Our credit ratings impact our future borrowing costs, access to
capital markets and future operating lease costs.

 

-7-

Contractual Obligations and Commitments

The following table lists our contractual obligations and commitments at August
31, 2006 (In Millions):

   
Payments Due by Period
     
Total
 
Less Than 1 Year
 
1-3 Years
 
3-5 Years
 
Over 5 Years
 
Operating leases (1)
 
$
26,086.3
 
$
1,457.8
 
$
3,020.8
 
$
2,956.3
 
$
18,651.4
 
Purchase obligations (2):
                               
Open inventory purchase orders
   
1,588.1
   
1,588.1
   
-
   
-
   
-
 
Real estate development
   
782.8
   
778.8
   
4.0
   
-
   
-
 
Other corporate obligations
   
588.0
   
240.8
   
231.3
   
102.0
   
13.9
 
Insurance*
   
449.9
   
145.1
   
160.0
   
79.0
   
65.8
 
Retiree health & life*
   
294.0
   
7.8
   
18.5
   
23.0
   
244.7
 
Closed location obligations*
   
69.8
   
17.0
   
25.5
   
14.7
   
12.6
 
Capital lease obligations*
   
39.6
   
.9
   
2.1
   
2.4
   
34.2
 
Other long-term liabilities reflected on the balance sheet*
   
479.1
   
42.7
   
55.9
   
46.9
   
333.6
 
Total
 
$
30,377.6
 
$
4,279.0
 
$
3,518.1
 
$
3,224.3
 
$
19,356.2
 

*Recorded on balance sheet.

(1)
Amounts for operating leases (nominal dollar) and capital leases do not include
certain operating expenses under these leases such as common area maintenance,
insurance and real estate taxes. These expenses for the company's most recent
fiscal year were $228.8 million.
(2)
Purchase obligations include agreements to purchase goods or services that are
enforceable and legally binding and that specify all significant terms,
including open purchase orders.

 

Off-Balance Sheet Arrangements

Letters of credit are issued to support purchase obligations and commitments (as
reflected on the Contractual Obligations and Commitments table) as follows (In
Millions):

Inventory obligations
$105.1
Real estate development
1.7
Insurance
282.2
Total
$389.0

We have no other off-balance sheet arrangements other than those disclosed on
the previous Contractual Obligations and Commitments table.

Both on-balance sheet and off-balance sheet financing are considered when
targeting debt to equity ratios to balance the interests of equity and debt
(real estate) investors. This balance allows us to lower our cost of capital
while maintaining a prudent level of financial risk.

Recent Accounting Pronouncements

In March 2005, the Financial Accounting Standards Board (FASB) issued Financial
Interpretation (FIN) 47, "Accounting for Conditional Asset Retirement
Obligations," which became effective in our fourth quarter fiscal 2006. This
interpretation clarifies that the term conditional asset retirement obligation
as used in FASB SFAS No. 143 refers to a legal obligation to perform an asset
retirement activity in which the timing and/or method of settlement are
conditional on a future event that may or may not be within the control of the
entity. We have adopted this interpretation and have determined that there is no
impact on our financial statements.

 

-8-

In May 2005, the FASB issued SFAS No. 154, "Accounting Changes and Error
Corrections," which will be effective in the first quarter of fiscal 2007. This
statement addresses the retrospective application of such changes and
corrections and will be followed if and when necessary.

In November 2005, the FASB issued Staff Position (FSP) 123(R)-3, "Transition
Election Related to Accounting for the Tax Effects of Share-Based Payment
Awards." This pronouncement provides an alternative transition method of
calculating the excess tax benefits available to absorb any tax deficiencies
recognized subsequent to the adoption of SFAS No. 123(R). The company has
elected to adopt the alternative transition method.

In June 2006, the FASB ratified Emerging Issues Task Force (EITF) Issue No.
06-3, "How Taxes Collected from Customers and Remitted to Governmental
Authorities Should Be Presented in the Income Statement (That Is, Gross versus
Net Presentation)." This pronouncement will be effective third quarter of fiscal
2007.
The task force reached a conclusion that either method is acceptable, however,
if taxes are reported on a gross basis (included as sales) a company should
disclose those amounts if significant. Sales taxes are not included in revenues;
however, we are still evaluating the impact of this pronouncement on other
taxes.

In July 2006, the FASB issued FIN 48, "Accounting for Uncertainty in Income
Taxes - an interpretation of FASB Statement No. 109." This interpretation
clarifies the accounting and disclosure for uncertain income tax positions,
which relate to the uncertainty about how certain income tax positions should be
reflected in the financial statements before they are resolved with the tax
authorities. This interpretation will be effective first quarter of fiscal 2008.
We are currently reviewing this pronouncement to determine the impact that it
may have on our consolidated financial position or results of operations.

In September 2006, the FASB issued SFAS No. 157, "Fair Value Measurements." This
statement defines and provides guidance when applying fair value measurements to
accounting pronouncements that require or permit such measurements. This
statement which will be effective first quarter of fiscal 2009, is not expected
to have a material impact on our consolidated financial position or results of
operations.

In September 2006, the Securities and Exchange Commission (SEC) issued Staff
Accounting Bulletin (SAB) No. 108. This SAB addresses diversity in practice in
quantifying financial statement misstatements. It also addresses the facts to
consider when evaluating the materiality of the error and the need to restate
the financial statements. This interpretation is effective for our first quarter
of fiscal 2007 and will be followed if and when necessary.

In October 2006, the FASB issued SFAS No. 158, "Employers' Accounting for
Defined Benefit Pension and Other Postretirement Plans." Companies will be
required to reflect the plan’s funded status on the balance sheet. The
difference between the plan’s funded status and its current balance sheet
position would be recognized, net of tax, as a component of Accumulated Other
Comprehensive Income. Had this statement been effective as of August 31, 2006,
the impact to Accumulated Other Comprehensive Income would have been $39.9
million. This pronouncement will be effective for the company's fourth quarter
of fiscal 2007.

Cautionary Note Regarding Forward-Looking Statements

Certain statements and projections of future results made in this report
constitute forward-looking information that is based on current market,
competitive and regulatory expectations that involve risks and uncertainties.
Please see Walgreen Co.'s Form 10-K for the period ended August 31, 2006, for a
discussion of important factors as they relate to forward-looking statements.
Actual results could differ materially.

 

-9-

Consolidated Statements of Earnings and Shareholders' Equity
Walgreen Co. and Subsidiaries
For the Years Ended August 31, 2006, 2005 and 2004
(In Millions, except shares and per share amounts)
Earnings
   
2006
   
2005
   
2004
 
Net Sales
 
$
47,409.0
 
$
42,201.6
 
$
37,508.2
 
Costs and Deductions:
                   
Cost of sales
   
34,240.4
   
30,413.8
   
27,310.4
 
Selling, occupancy and administration
   
10,467.1
   
9,363.8
   
8,055.4
       
44,707.5
   
39,777.6
   
35,365.8
 
Other Income:
                   
Interest income
   
52.6
   
31.6
   
17.3
 
Earnings:
                   
Earnings before income tax provision
   
2,754.1
   
2,455.6
   
2,159.7
 
Income tax provision
   
1,003.5
   
896.1
   
809.9
 
Net Earnings
 
$
1,750.6
 
$
1,559.5
 
$
1,349.8
 
Net Earnings per Common Share:
                   
Basic
 
$
1.73
 
$
1.53
 
$
1.32
 
Diluted
   
1.72
   
1.52
   
1.31
 
Average shares outstanding
   
1,010,252,562
   
1,019,669,630
   
1,024,512,865
 
Dilutive effect of stock options
   
9,148,162
   
8,664,212
   
7,285,553
 
Average shares outstanding assuming dilution
   
1,019,400,724
   
1,028,333,842
   
1,031,798,418
 

                           
Shareholders' Equity
 
Common Stock Shares
 
Common Stock Amount
 
Paid-In Capital
 
Employee Stock Loan Receivable
 
Retained Earnings
 
Common Stock in Treasury
 
Balance, August 31, 2003
   
1,024,908,276
 
$
80.1
 
$
697.8
 
$
-
 
$
6,339.9
 
$
-
 
Net earnings
   
-
   
-
   
-
   
-
   
1,349.8
   
-
 
Cash dividends declared ($.181875 per share)
   
-
   
-
   
-
   
-
   
(186.4
)
 
-
 
Treasury stock purchases
   
(8,518,500
)
 
-
   
-
   
-
   
-
   
(299.2
)
Employee stock purchase and option plans
   
6,902,961
   
-
   
(65.2
)
 
-
   
-
   
222.9
 
Balance, August 31, 2004
   
1,023,292,737
   
80.1
   
632.6
   
-
   
7,503.3
   
(76.3
)
Net earnings
   
-
   
-
   
-
   
-
   
1,559.5
   
-
 
Cash dividends declared ($.2225 per share)
   
-
   
-
   
-
   
-
   
(226.5
)
 
-
 
Treasury stock purchases
   
(18,135,900
)
 
-
   
-
   
-
   
-
   
(781.8
)
Employee stock purchase and option plans
   
8,355,210
   
-
   
(67.6
)
 
-
   
-
   
343.2
 
Employee stock loan receivable
   
-
   
-
   
-
   
(76.8
)
 
-
   
-
 
Balance, August 31, 2005
   
1,013,512,047
   
80.1
   
565.0
   
(76.8
)
 
8,836.3
   
(514.9
)
Net earnings
   
-
   
-
   
-
   
-
   
1,750.6
   
-
 
Cash dividends declared ($.2725 per share)
   
-
   
-
   
-
   
-
   
(275.2
)
 
-
 
Treasury stock purchases
   
(15,033,000
)
 
-
   
-
   
-
   
-
   
(668.8
)
Employee stock purchase and option plans
   
9,383,072
   
-
   
(159.1
)
 
-
   
-
   
419.5
 
Stock-based compensation
   
-
   
-
   
152.6
   
-
   
-
   
-
 
Employee stock loan receivable
   
-
   
-
   
-
   
6.5
   
-
   
-
 
Balance, August 31, 2006
   
1,007,862,119
 
$
80.1
 
$
558.5
 
$
(70.3
)
$
10,311.7
 
$
(764.2
)

The accompanying Summary of Major Accounting Policies and the Notes to
Consolidated Financial Statements are integral parts of these statements.
 

-10-

Consolidated Balance Sheets
Walgreen Co. and Subsidiaries
At August 31, 2006 and 2005
(In Millions, except shares and per share amounts)

   
Assets
 
2006
 
2005
 
Current Assets
             
Cash and cash equivalents
 
$
919.9
 
$
576.8
 
Short-term investments - available for sale
   
415.1
   
494.8
 
Accounts receivable, net
   
2,062.7
   
1,396.3
 
Inventories
   
6,050.4
   
5,592.7
 
Other current assets
   
257.3
   
255.9
 
Total Current Assets
   
9,705.4
   
8,316.5
 
Non-Current Assets
             
Property and equipment, at cost, less accumulated depreciation and amortization
   
6,948.9
   
6,165.0
 
Other non-current assets
   
476.8
   
127.3
 
Total Assets
 
$
17,131.1
 
$
14,608.8
                 
Liabilities and Shareholders' Equity
             
Current Liabilities
             
Trade accounts payable
 
$
4,039.2
 
$
2,918.2
 
Accrued expenses and other liabilities
   
1,713.3
   
1,491.9
 
Income taxes
   
2.8
   
70.9
 
Total Current Liabilities
   
5,755.3
   
4,481.0
 
Non-Current Liabilities
             
Deferred income taxes
   
141.1
   
240.4
 
Other non-current liabilities
   
1,118.9
   
997.7
 
Total Non-Current Liabilities
   
1,260.0
   
1,238.1
 
Shareholders' Equity
             
Preferred stock, $.0625 par value; authorized 32 million shares; none issued
   
-
   
-
 
Common stock, $.078125 par value; authorized 3.2 billion shares; issued
1,025,400,000 shares in 2006 and 2005
   
80.1
   
80.1
 
Paid-in capital
   
558.5
   
565.0
 
Employee stock loan receivable
   
(70.3
)
 
(76.8
)
Retained earnings
   
10,311.7
   
8,836.3
 
Treasury stock at cost, 17,537,881 shares in 2006 and 11,887,953 shares in 2005
   
(764.2
)
 
(514.9
)
Total Shareholders' Equity
   
10,115.8
   
8,889.7
 
Total Liabilities and Shareholders' Equity
 
$
17,131.1
 
$
14,608.8
 

The accompanying Summary of Major Accounting Policies and the Notes to
Consolidated Financial Statements are integral parts of these statements.

 

-11-

Consolidated Statements of Cash Flows
Walgreen Co. and Subsidiaries
For the Years Ended August 31, 2006, 2005 and 2004
(In Millions)

       
2006
 
2005
 
2004
 
Cash Flows from Operating Activities
                   
Net earnings
 
$
1,750.6
 
$
1,559.5
 
$
1,349.8
 
Adjustments to reconcile net earnings to net cash provided by operating
activities -
                   
Depreciation and amortization
   
572.2
   
482.1
   
403.1
 
Deferred income taxes
   
(104.0
)
 
(70.8
)
 
66.0
 
Stock compensation expense
   
102.5
   
-
   
-
 
Income tax savings from employee stock plans
   
8.1
   
33.9
   
50.3
 
Other
   
67.3
   
74.5
   
38.8
 
Changes in operating assets and liabilities -
                   
Inventories
   
(375.7
)
 
(854.0
)
 
(536.0
)
Trade accounts payable
   
875.6
   
276.7
   
233.7
 
Accounts receivable, net
   
(618.5
)
 
(224.9
)
 
(171.6
)
Accrued expenses and other liabilities
   
197.2
   
97.8
   
207.6
 
Income taxes
   
(68.4
)
 
5.0
   
(39.9
)
Other
   
32.7
   
(8.6
)
 
42.2
 
Net cash provided by operating activities
   
2,439.6
   
1,371.2
   
1,644.0
 
Cash Flows from Investing Activities
                   
Purchases of short-term investments - available for sale
   
(12,282.4
)
 
(10,742.0
)
 
(11,938.2
)
Proceeds from sale of short-term investments - available for sale
   
12,388.4
   
11,519.9
   
10,695.4
 
Additions to property and equipment
   
(1,337.8
)
 
(1,237.5
)
 
(939.5
)
Disposition of property and equipment
   
23.0
   
15.5
   
6.2
 
Net proceeds from corporate-owned life insurance
   
10.7
   
10.1
   
10.2
 
Business acquisitions, net of cash received
   
(485.4
)
 
-
   
-
 
Net cash used for investing activities
   
(1,683.5
)
 
(434.0
)
 
(2,165.9
)
Cash Flows from Financing Activities
                   
Stock purchases
   
(668.8
)
 
(781.8
)
 
(299.2
)
Proceeds from employee stock plans
   
319.1
   
177.5
   
145.1
 
Cash dividends paid
   
(262.9
)
 
(214.5
)
 
(176.9
)
Bank overdrafts
   
213.9
   
-
   
-
 
Other
   
(14.3
)
 
14.4
   
28.9
 
Net cash used for financing activities
   
(413.0
)
 
(804.4
)
 
(302.1
)
Changes in Cash and Cash Equivalents
                   
Net increase (decrease) in cash and cash equivalents
   
343.1
   
132.8
   
(824.0
)
Cash and cash equivalents at beginning of year
   
576.8
   
444.0
   
1,268.0
 
Cash and cash equivalents at end of year
 
$
919.9
 
$
576.8
 
$
444.0
 

The accompanying Summary of Major Accounting Policies and the Notes to
Consolidated Financial Statements are integral parts of these statements.

 

-12-

Summary of Major Accounting Policies
Description of Business

The company is principally in the retail drugstore business and its operations
are within one reportable segment. At August 31, 2006, there were 5,461 stores,
located in 47 states and Puerto Rico. Prescription sales were 64.3% of total
sales for fiscal 2006 compared to 63.7% in 2005 and 63.2% in 2004.

Basis of Presentation

The consolidated statements include the accounts of the company and its
subsidiaries. All significant intercompany transactions have been eliminated.
The consolidated financial statements are prepared in accordance with accounting
principles generally accepted in the United States of America and include
amounts based on management's prudent judgments and estimates. Actual results
may differ from these estimates.

Cash and Cash Equivalents

Cash and cash equivalents include cash on hand and all highly liquid investments
with an original maturity of three months or less. Included in cash and cash
equivalents are credit card and debit card receivables from banks, which settle
within two business days, of $54.7 million at August 31, 2006, and $55.4 million
at August 31, 2005. The company's cash management policy provides for controlled
disbursement. As a result, the company maintains overdraft positions at certain
banks. Such overdrafts, which were $575.3 million as of August 31, 2006, and
$339.4 million as of August 31, 2005, are included in trade accounts payable in
the accompanying consolidated balance sheets.

Short-Term Investments - Available for Sale

The company's short-term investments - available for sale are principally
auction rate securities. The company invests in municipal bonds and student
obligations and purchases these securities at par. The underlying security is
issued as a long-term investment. However, auction rate securities are
classified as short-term investments because they typically can be purchased and
sold every 7, 28 and 35 days. The trading of auction rate securities takes place
through a descending price auction with the interest rate reset at the beginning
of each holding period. At the end of each holding period the interest is paid
to the investor. The unrealized gains on these securities at August 31, 2006 and
2005, were not significant.

Financial Instruments

The company had $105.1 million and $66.2 million of outstanding letters of
credit at August 31, 2006 and 2005, respectively, which guarantee foreign trade
purchases. Additional outstanding letters of credit of $282.2 million and $313.8
million at August 31, 2006 and 2005, respectively, guarantee payments of
casualty claims. The casualty claim letters of credit are annually renewable and
will remain in place until the casualty claims are paid in full. Letters of
credit of $1.7 million were outstanding at both August 31, 2006 and 2005, to
guarantee performance of construction contracts. The company pays a nominal
facility fee to the financing bank to keep these letters of credit active. The
company also had purchase commitments of approximately $782.8 million and $437.6
million at August 31, 2006 and 2005, respectively, related to the purchase of
store locations and distribution centers. There were no investments in
derivative financial instruments during fiscal 2006 and 2005.

 

-13-

Inventories

Inventories are valued on a lower of last-in, first-out (LIFO) cost or market
basis. At August 31, 2006 and 2005, inventories would have been greater by
$899.5 million and $804.2 million, respectively, if they had been valued on a
lower of first-in, first-out (FIFO) cost or market basis. Inventory includes
product cost and inbound freight. Cost of sales is primarily derived based upon
point-of-sale scanning information with an estimate for shrinkage and is
adjusted based on periodic inventories. In addition to merchandise cost, cost of
sales includes warehousing costs, purchasing costs, freight costs and vendor
allowances not included as a reduction of advertising expense.

Vendor Allowances

Vendor allowances are principally received as a result of purchase levels, sales
or promotion of vendors' products. Allowances are generally recorded as a
reduction of inventory and are recognized as a reduction of cost of sales when
the related merchandise is sold. Those allowances received for promoting
vendors' products are offset against advertising expense and result in a
reduction of selling, occupancy and administration expenses to the extent of
advertising costs incurred, with the excess treated as a reduction of inventory
costs.

Property and Equipment

Depreciation is provided on a straight-line basis over the estimated useful
lives of owned assets. Leasehold improvements and leased properties under
capital leases are amortized over the estimated physical life of the property or
over the term of the lease, whichever is shorter. Estimated useful lives range
from 12 1/2 to 39 years for land improvements, buildings and building
improvements and 3 to 12 1/2 years for equipment. Major repairs, which extend
the useful life of an asset, are capitalized in the property and equipment
accounts. Routine maintenance and repairs are charged against earnings. The
composite method of depreciation is used for equipment; therefore, gains and
losses on retirement or other disposition of such assets are included in
earnings only when an operating location is closed, completely remodeled or
impaired. Fully depreciated property and equipment are removed from the cost and
related accumulated depreciation and amortization accounts. Property and
equipment consists of (In Millions):

   
2006
 
2005
 
Land and land improvements
             
Owned stores
 
$
1,667.4
 
$
1,459.4
 
Distribution centers
   
94.2
   
81.6
 
Other locations
   
93.5
   
59.1
 
Buildings and building improvements
             
Owned stores
   
1,824.6
   
1,521.3
 
Leased stores (leasehold improvements only)
   
537.6
   
500.5
 
Distribution centers
   
483.4
   
453.0
 
Other locations
   
229.0
   
183.5
 
Equipment
             
Stores
   
3,157.7
   
2,853.9
 
Distribution centers
   
773.3
   
679.8
 
Other locations
   
214.4
   
166.0
 
Capitalized system development costs
   
171.7
   
143.7
 
Capital lease properties
   
40.2
   
48.4
       
9,287.0
   
8,150.2
 
Less: accumulated depreciation and amortization
   
2,338.1
   
1,985.2
     
$
6,948.9
 
$
6,165.0
 

 

-14-

The company capitalizes application stage development costs for significant
internally developed software projects, including "SIMS Plus," a strategic
inventory management system, and "Ad Planning," an advertising system. These
costs are amortized over a five-year period. Amortization was $24.2 million in
2006, $20.4 million in 2005 and $19.0 million in 2004. Unamortized costs as of
August 31, 2006 and 2005, were $109.6 million and $90.1 million, respectively.

Revenue Recognition

The company recognizes revenue at the time the customer takes possession of the
merchandise. Customer returns are immaterial.

Impaired Assets and Liabilities for Store Closings

The company tests long-lived assets for impairment whenever events or
circumstances indicate. Store locations that have been open at least five years
are reviewed for impairment indicators at least annually. Once identified, the
amount of the impairment is computed by comparing the carrying value of the
assets to the fair value, which is based on the discounted estimated future cash
flows. Included in selling, occupancy and administration expense were impairment
charges of $22.1 million in 2006, $14.5 million in 2005 and $9.2 million in
2004.

The company also provides for future costs related to closed locations. The
liability is based on the present value of future rent obligations and other
related costs (net of estimated sublease rent) to the first lease option date.

Insurance

The company obtains insurance coverage for catastrophic exposures as well as
those risks required by law to be insured. It is the company's policy to retain
a significant portion of certain losses related to workers' compensation;
property losses, as well as business interruption relating from such losses; and
comprehensive general, pharmacist and vehicle liability. Provisions for these
losses are recorded based upon the company's estimates for claims incurred. The
provisions are estimated in part by considering historical claims experience,
demographic factors and other actuarial assumptions.

Pre-Opening Expenses

Non-capital expenditures incurred prior to the opening of a new or remodeled
store are expensed as incurred.

Advertising Costs

Advertising costs, which are reduced by the portion funded by vendors, are
expensed as incurred. Net advertising expenses, which are included in selling,
occupancy and administration expense, were $306.9 million in 2006, $260.3
million in 2005 and $230.9 million in 2004. Included in net advertising expenses
were vendor advertising allowances of $174.8 million in 2006, $180.2 million in
2005 and $163.6 million in 2004.

 

-15-

Stock-Based Compensation Plans

As of September 1, 2005, the company adopted Statement of Financial Accounting
Standards (SFAS) No. 123(R), "Share-Based Payment," using the modified
prospective transition method. Under this method, compensation expense is
recognized for new grants beginning this fiscal year and any unvested grants
prior to the adoption of SFAS No. 123(R). The company recognizes compensation
expense on a straight-line basis over the employee's vesting period or to the
employee's retirement eligible date, if earlier. In accordance with the modified
prospective transition method, the financial statements for prior periods have
not been restated.

Prior to September 1, 2005, as permitted under SFAS No. 123, "Accounting for
Stock-Based Compensation," the company applied Accounting Principles Board (APB)
Opinion No. 25 and related interpretations in accounting for its stock-based
compensation plans. Under APB Opinion No. 25, compensation expense was
recognized for stock option grants if the exercise price was below the fair
value of the underlying stock at the measurement date.

As a result of adopting SFAS No. 123(R), our earnings before income tax expense
and net earnings for the fiscal year-end were $102.5 million and $59.3 million
lower, respectively, than if the stock-based compensation was still accounted
for under APB Opinion No. 25. The recognized tax benefit was $36.7 million.

As of August 31, 2006, there was $46.9 million of total unrecognized
compensation cost related to nonvested awards. This cost is expected to be
recognized over a weighted average of 1.56 years.

Prior to fiscal 2006, the company presented all tax benefits of deductions
resulting from the exercise of stock options as operating cash flows in the
Consolidated Statement of Cash Flows. SFAS No. 123(R) requires excess tax
benefits, the cash flow resulting from the tax deductions in excess of the
compensation cost recognized for those options, to be classified as financing
cash flows. The total excess tax benefit for fiscal 2006 was $56.5 million.

Had compensation costs been determined consistent with the method of SFAS No.
123 for options granted in fiscal 2005 and 2004, pro forma net earnings and net
earnings per common share would have been as illustrated in the following table
(In Millions, except per share amounts):

   
2005
 
2004
 
Net earnings
 
$
1,559.5
 
$
1,349.8
 
Add:
             
Stock-based employee compensation expenses included in reported net income, net
of related tax effects
   
.2
   
.4
 
Deduct:
             
Total stock-based employee compensation expense determined under fair value
based method for all awards, net of related tax effects
   
(72.5
)
 
(44.1
)
Pro forma net income
 
$
1,487.2
 
$
1,306.1
 
Earnings per share:
             
Basic - as reported
 
$
1.53
 
$
1.32
 
Basic - pro forma
   
1.46
   
1.27
                 
Diluted - as reported
   
1.52
   
1.31
 
Diluted - pro forma
   
1.45
   
1.27
 

Income Taxes

The company provides for federal and state income taxes on items included in the
Consolidated Statements of Earnings regardless of the period when such taxes are
payable. Deferred taxes are recognized for temporary differences between
financial and income tax reporting based on enacted tax laws and rates.

-16-

Earnings Per Share

The dilutive effect of outstanding stock options on earnings per share is
calculated using the treasury stock method. Stock options are anti-dilutive and
excluded from the earnings per share calculation if the exercise price exceeds
the market price of the common shares. At August 31, 2006, and August 31, 2004,
outstanding options to purchase 3,505,834 and 2,902,996 common shares were
excluded from fiscal year 2006 and 2004 calculations, respectively. There were
no anti-dilutive shares related to stock options in fiscal 2005.

Interest Expense

The company capitalized $3.3 million, $4.2 million and $1.1 million of interest
expense as part of significant construction projects during fiscal 2006, 2005
and 2004, respectively. Fiscal 2006 had no interest paid, net of amounts
capitalized, compared to $.8 million in 2005 and $.2 million in 2004.

 

-17-

Notes to Consolidated Financial Statements

Hurricane Katrina

In fiscal 2005, the company provided for $54.7 million of pre-tax expenses
related to Hurricane Katrina. During fiscal 2006, the company recorded a $12.3
million downward adjustment of the Hurricane Katrina expenses.

Leases

The company owns 18.3% of its locations; the remaining locations are leased
premises. Initial terms are typically 20 to 25 years, followed by additional
terms containing cancellation options at five-year intervals, and may include
rent escalation clauses. The commencement date of all lease terms is the earlier
of the date the company becomes legally obligated to make rent payments or the
date the company has the right to control the property. Additionally, the
company recognizes rent expense on a straight-line basis over the term of the
lease. In addition to minimum fixed rentals, most leases provide for contingent
rentals based upon a portion of sales.

Minimum rental commitments at August 31, 2006, under all leases having an
initial or remaining non-cancelable term of more than one year are shown below
(In Millions):
2007
 
$
1,495.8
 
2008
   
1,549.6
 
2009
   
1,537.6
 
2010
   
1,515.3
 
2011
   
1,492.4
 
Later
   
18,879.8
 
Total minimum lease payments
 
$
26,470.5
 

The above minimum lease payments include minimum rental commitments related to
capital leases of $69.5 million at August 31, 2006. This capital lease amount
includes $31.7 million of executory costs and imputed interest. Total minimum
lease payments have not been reduced by minimum sublease rentals of
approximately $43.5 million on leases due in the future under non-cancelable
subleases.

The company remains secondarily liable on 22 assigned leases. The maximum
potential of undiscounted future payments is $6.7 million as of August 31, 2006.
Lease option dates vary, with some extending to 2014.

Rental expense was as follows (In Millions):

   
2006
 
2005
 
2004
 
Minimum rentals
 
$
1,428.5
 
$
1,300.7
 
$
1,152.1
 
Contingent rentals
   
15.9
   
18.7
   
20.3
 
Less: Sublease rental income
   
(12.5
)
 
(12.5
)
 
(11.9
)
   
$
1,431.9
 
$
1,306.9
 
$
1,160.5
 

Goodwill and Other Intangible Assets

The carrying amount and accumulated amortization of goodwill and intangible
assets consists of the following (In Millions):

 

-18-

 

   
2006
 
2005
 
Purchased prescription files
 
$
224.0
 
$
86.9
 
Purchasing and payor contracts
   
55.0
   
-
 
Trade name
   
31.3
   
-
 
Other amortizable intangible assets
   
26.1
   
21.7
 
Goodwill
   
168.4
   
10.3
 
Gross carrying amount
   
504.8
   
118.9
                 
Accumulated amortization - prescription files
   
(55.4
)
 
(25.6
)
Purchasing and payor contracts
   
(3.4
)
 
-
 
Trade name
   
(1.1
)
 
-
 
Accumulated amortization - other
   
(10.2
)
 
(9.3
)
Total accumulated amortization
   
(70.1
)
 
(34.9
)
Total intangible assets, net
 
$
434.7
 
$
84.0
 

The company completed a merger with Happy Harry’s, a drugstore chain, on July 1,
2006. In addition, the company acquired 100% ownership of Schraft’s and Medmark,
both of which are specialty pharmacies, on November 3, 2005 and August 1, 2006,
respectively. These business acquisitions have been included in the company's
operating statements since their respective acquisition dates. Happy Harry’s
will add to the company’s drugstore presence in the Northeast while Schraft's
and Medmark are part of the expansion into the specialty pharmacy industry.

The aggregate purchase price of all business acquisitions was $485.4 million.
These acquisitions added $137.1 million to prescription files, $55.0 million to
purchasing and payor contracts, $31.3 million to trade names, $4.4 million to
other amortizable intangibles and $158.1 million to goodwill ($21.3 million is
expected to be deductible for tax purposes). The remaining fair value relates to
tangible assets. Pro forma results of operations of the company for fiscal years
2006, 2005 and 2004 would not be materially different as a result of these
acquisitions and are therefore not presented.

Amortization expense for intangible assets was $45.6 million in 2006, $18.5
million in 2005 and $8.8 million in 2004. The weighted-average amortization
period for purchased prescription files was five years for fiscal 2006 and
fiscal 2005. The weighted-average amortization period for purchasing and payor
contracts and trade names was ten years in fiscal 2006. The weighted-average
amortization period for other intangible assets was nine years for fiscal 2006
and eleven years for fiscal 2005. Goodwill is evaluated annually during the
fourth quarter of the company's fiscal year. No impairment loss related to
goodwill occurred in either fiscal 2006 or fiscal 2005.

Expected amortization expense for intangible assets recorded at August 31, 2006,
is as follows (In Millions):
2007
2008
2009
2010
2011
$56.4
$53.6
$49.6
$40.6
$24.6

Income Taxes

The provision for income taxes consists of the following (In Millions):

     
2006
   
2005
   
2004
 
Current provision -
                   
Federal
 
$
970.1
 
$
841.4
 
$
632.5
 
State
   
137.4
   
125.5
   
111.4
       
1,107.5
   
966.9
   
743.9
 
Deferred provision -
                   
Federal
   
(88.8
)
 
(57.8
)
 
65.3
 
State
   
(15.2
)
 
(13.0
)
 
.7
       
(104.0
)
 
(70.8
)
 
66.0
     
$
1,003.5
 
$
896.1
 
$
809.9
 

 

-19-

The deferred tax assets and liabilities included in the Consolidated Balance
Sheets consist of the following (In Millions):

   
2006
 
2005
 
Deferred tax assets -
             
Employee benefit plans
 
$
303.9
 
$
263.5
 
Insurance
   
178.4
   
157.5
 
Accrued rent
   
130.5
   
118.5
 
Inventory
   
41.0
   
40.8
 
Bad debt
   
37.0
   
14.3
 
Stock compensation expense
   
35.0
   
-
 
Other
   
49.8
   
61.4
       
775.6
   
656.0
 
Deferred tax liabilities -
             
Accelerated depreciation
   
643.7
   
663.4
 
Inventory
   
142.1
   
112.8
 
Other
   
30.9
   
25.9
       
816.7
   
802.1
 
Net deferred tax liabilities
 
$
41.1
 
$
146.1
 

Income taxes paid were $1.111 billion, $928.2 million and $734.1 million during
the fiscal years ended August 31, 2006, 2005 and 2004, respectively. The
difference between the statutory income tax rate and the effective tax rate is
principally due to state income tax provisions.

Short-Term Borrowings

The company had no short-term borrowings in fiscal 2006 or 2005. At August 31,
2006, the company had a syndicated bank line of credit facility of $200 million
to support the company's short-term commercial paper program. The company pays a
nominal facility fee to the financing bank to keep this line of credit facility
active.

Contingencies

The company is involved in various legal proceedings incidental to the normal
course of business and is subject to various investigations, inspections,
audits, inquiries and similar actions by governmental authorities responsible
for enforcing the laws and regulations to which the company is subject. These
include a lawsuit for which a $31 million judgment was entered against the
company in October 2006. The company has appealed the judgment and management is
of the opinion, based upon the advice of General Counsel, that although the
outcome of this and other litigation and investigations cannot be forecast with
certainty, the final disposition should not have a material adverse effect on
the company's consolidated financial position or results of operations.

Capital Stock

On July 14, 2004, the Board of Directors announced a stock repurchase program of
up to $1 billion, which is expected to be executed over four years. During
fiscal 2006, the company purchased $289.7 million of shares related to the stock
repurchase program, which compares to $345.1 million of shares purchased in
fiscal 2005. Total purchases to date related to the stock repurchase program
have been $656.8 million. An additional $379.1 million of shares were purchased
to support the long-term needs of the employee stock plans, which compares to
$436.7 million in fiscal 2005.

At August 31, 2006, 86,104,397 shares of common stock were reserved for future
stock issuances under the company's various employee benefit plans.

 

-20-

Stock Compensation Plans

The Walgreen Co. Stock Purchase/Option Plan (Share Walgreens) provides for the
granting of options to purchase common stock over a ten-year period to eligible
non-executive employees upon the purchase of company shares, subject to certain
restrictions. Employees may purchase the company shares through cash purchases
or loans. For options granted on or after October 1, 2005, the option price is
the closing price of a share of common stock on the grant date. Options may be
granted under this Plan until September 30, 2012, for an aggregate of 42,000,000
shares of common stock. At August 31, 2006, there were 31,754,614 shares
available for future grants. The options granted during fiscal 2006, 2005 and
2004 have a two-year vesting period.

The Walgreen Co. Executive Stock Option Plan provides for the granting of
options to eligible key employees to purchase common stock over a ten-year
period, at a price not less than the fair market value on the date of the grant.
Under this Plan, options may be granted until January 11, 2016, for an aggregate
of 38,400,000 shares of common stock. As of August 31, 2006, 17,658,026 shares
were available for future grants. The options granted during fiscal 2006, 2005
and 2004 have a three-year vesting period.  

The Walgreen Co. Option 3000 Plan offered a stock option award to all
non-executive employees who were employed on May 11, 2000. Each eligible
employee, in conjunction with opening the company’s 3,000th store, received a
stock option award to purchase from 75 to 500 shares, based on years of service.
The option award, issued at fair market value on May 11, 2000, was authorized to
grant an aggregate of 15,500,000 shares of common stock. The options vested and
became exercisable on May 11, 2003, and any unexercised options will expire on
May 10, 2010, subject to earlier termination if the optionee’s employment ends.

The Walgreen Co. Broad Based Employee Stock Option Plan provides for the
granting of options to eligible non-executive employees to purchase common stock
over a ten-year period, at a price not less than the fair market value on the
date of the grant, in connection with the achievement of store opening
milestones. Under this Plan, on March 11, 2003, substantially all non-executive
employees, in conjunction with the opening of the company's 4,000th store, were
granted a stock option to purchase 100 shares. The option was authorized to
grant an aggregate of 15,000,000 shares of common stock. The options vested and
became exercisable on March 11, 2006, and any unexercised options will expire on
March 10, 2013, subject to earlier termination if the optionee’s employment
ends.

The Walgreen Co. 1982 Employees Stock Purchase Plan permits eligible employees
to purchase common stock at 90% of the fair market value at the date of
purchase. Employees may purchase shares through cash purchases, loans or payroll
deductions up to certain limits. The aggregate number of shares, which all
participants have the right to purchase under this Plan, is 74,000,000. At
August 31, 2006, 6,840,369 shares were available for future purchase.

The Walgreen Co. Restricted Performance Share Plan provides for the granting of
shares of common stock and cash to certain key employees, subject to
restrictions as to continuous employment except in the case of death, normal
retirement or total and permanent disability. Restrictions generally lapse over
a four-year period from the date of grant. Compensation expense is recognized in
the year of grant. Shares may be granted for an aggregate of 32,000,000 shares
of common stock. At August 31, 2006, 22,938,127 shares were available for future
purchases. Compensation expense related to the Plan was $8.8 million in fiscal
2006, $11.1 million in fiscal 2005 and $8.1 million in fiscal 2004.

 

-21-

The Walgreen Co. Nonemployee Director Stock Plan provides that each nonemployee
director receives an equity grant of shares each year on November 1. Through
fiscal 2006, the plan determined the number of shares granted by dividing
$80,000 by the price of a share of common stock on November 1. Beginning with
the annual share grant made on November 1, 2006, the dollar value of the grant
has increased to $100,000, and each nonemployee director may elect to receive
this annual share grant in the form of shares or deferred stock units. During
the term of the Plan, each nonemployee director will also receive 50% of his or
her quarterly retainer in the form of shares, which may be deferred into an
equal number of stock units. In addition, a nonemployee director may elect to
defer all or a portion of the cash component of his or her quarterly retainer,
meeting fees and committee chair retainer in the form of deferred stock units or
to have such amounts placed in a deferred cash compensation account. Each
nonemployee director received a grant of 1,771 shares in 2006, excluding any new
directors which were prorated. Each nonemployee director received a grant of
2,211 shares in 2005 and 2,298 shares in 2004.

A summary of information relative to the company's stock option plans follows:
Options
 
Shares
 
Weighted-Average Exercise Price
 
Weighted-Average Remaining Contractual Term
 
Aggregate Intrinsic Value
 
Outstanding at August 31, 2005
   
42,905,655
 
$
29.58
             
Granted
   
3,544,433
   
46.08
             
Exercised
   
(7,707,687
)
 
22.92
             
Canceled/Forfeited
   
(1,334,954
)
 
31.21
             
Outstanding at August 31, 2006
   
37,407,447
 
$
32.45
   
5.95 years
 
$
636,271,916
                             
Exercisable at August 31, 2006
   
22,926,046
 
$
29.03
   
4.55 years
 
$
468,476,226
 

The intrinsic value for options exercised in fiscal 2006, 2005 and 2004 was
$173.0 million, $89.3 million and $132.0 million, respectively. The total fair
value of options vested in fiscal 2006, 2005 and 2004 was $116.3 million, $31.5
million and $36.1 million, respectively.

Cash received from the exercise of options in fiscal 2006 was $176.7 million.
The related tax benefit realized was $66.1 million. The company has a practice
of repurchasing shares on the open market to satisfy share-based payment
arrangements and expects to repurchase approximately eight million shares during
fiscal 2007.

A summary of information relative to the company's restricted stock awards
follows:
Nonvested Shares
 
Shares
 
Weighted-Average Grant-Date Fair Value
 
Nonvested at August 31, 2005
   
127,539
 
$
35.28
 
Granted
   
134,768
   
46.33
 
Forfeited
   
-
   
-
 
Vested
   
(104,487
)
 
42.44
 
Nonvested at August 31, 2006
   
157,820
 
$
41.92
 

 

-22-

 
The fair value of each option grant was determined using the Black-Scholes
option pricing model with weighted-average assumptions used in fiscal 2006, 2005
and 2004:

   
2006
 
2005
 
2004
 
Risk-free interest rate (1)
   
4.10
%
 
3.80
%
 
4.07
%
Average life of option (years) (2)
   
7.2
   
7.2
   
7.0
 
Volatility (3)
   
32.12
%
 
28.14
%
 
28.56
%
Dividend yield (4)
   
.45
%
 
.58
%
 
.38
%
Weighted-average grant-date fair value
                   
    Granted at market price
 
$
18.82
 
$
13.47
 
$
12.17
 
    Granted below market price
   
-
 
$
12.78
 
$
14.03
 

 
(1)
Represents the Treasury bill rate for the expected term of the option.
(2)
Represents the period of time that options granted are expected to be
outstanding. The company analyzed separate groups of employees with similar
exercise behavior to determine the expected term.
(3)
Based on historical volatility of the company’s common stock.
(4)
Represents the company’s cash dividend for the expected term.

Retirement Benefits

The principal retirement plan for employees is the Walgreen Profit-Sharing
Retirement Trust to which both the company and the employees contribute. The
company's contribution, which is determined annually at the discretion of the
Board of Directors, has historically related to pre-tax income. The
profit-sharing provision was $245.0 million in 2006, $218.5 million in 2005 and
$193.6 million in 2004. The company's contributions were $216.1 million for
2006, $262.3 million for 2005 and $161.5 million for 2004.

The company provides certain health insurance benefits for retired employees who
meet eligibility requirements, including age, years of service and date of hire.
The costs of these benefits are accrued over the period earned. The company's
postretirement health benefit plans are not funded.

Components of net periodic benefit costs (In Millions):

   
2006
 
2005
 
2004
 
Service cost
 
$
18.3
 
$
22.0
 
$
19.3
 
Interest cost
   
21.4
   
23.6
   
22.5
 
Amortization of actuarial loss
   
8.8
   
10.6
   
9.9
 
Amortization of prior service cost
   
(4.1
)
 
(3.6
)
 
(.4
)
Transition obligation
   
-
   
4.9
   
-
 
Total postretirement benefit cost
 
$
44.4
 
$
57.5
 
$
51.3
 

Change in benefit obligation (In Millions):

   
2006
 
2005
 
Benefit obligation at September 1
 
$
391.8
 
$
392.5
 
Service cost
   
18.3
   
22.0
 
Interest cost
   
21.4
   
23.6
 
Amendments
   
(5.0
)
 
(36.7
)
Actuarial gain
   
(62.7
)
 
(6.6
)
Benefit payments
   
(9.1
)
 
(8.7
)
Participants contributions
   
1.0
   
.8
 
Medicare Part D subsidy
   
.3
   
-
 
Transition obligation
   
-
   
4.9
 
Benefit obligation at August 31
 
$
356.0
 
$
391.8
 

 

-23-

 
Change in plan assets (In Millions):

   
2006
 
2005
 
Plan assets at fair value at September 1
 
$
-
 
$
-
 
Plan participants contributions
   
1.0
   
.8
 
Employer contributions
   
7.8
   
7.9
 
Benefits paid
   
(9.1
)
 
(8.7
)
Medicare Part D subsidy
   
.3
   
-
 
Plan assets at fair value at August 31
 
$
-
 
$
-
 

Funded status (In Millions):

   
2006
 
2005
 
Funded status
 
$
(356.0
)
$
(391.8
)
Unrecognized actuarial loss
   
130.7
   
203.0
 
Unrecognized prior service cost
   
(66.1
)
 
(65.2
)
Accrued benefit cost at August 31
 
$
(291.4
)
$
(254.0
)

The measurement date used to determine the postretirement benefits is as of
August 31, 2006 and 2005. The discount rate assumption used to compute the
postretirement benefit obligation at year-end was 6.25% for 2006 and 5.5% for
2005. The discount rate assumption used to determine net periodic benefit cost
was 5.5% for 2006 and 2005, and 6.5% for 2004.

Future benefit costs were estimated assuming medical costs would increase at a
9.25% annual rate gradually decreasing to 5.25% over the next five years and
then remaining at a 5.25% annual growth rate thereafter. A one percentage point
change in the assumed medical cost trend rate would have the following effects
(In Millions):

   
1% Increase
 
1% Decrease
 
Effect on service and interest cost
 
$
.9
 
$
(1.1
)
Effect on postretirement obligation
   
16.6
   
(20.1
)

Estimated future benefit payments and federal subsidy (In Millions):

   
Estimated Future Benefit Payments
 
Estimated Federal Subsidy
 
2007
 
$
8.8
 
$
1.0
 
2008
   
9.5
   
1.2
 
2009
   
10.8
   
1.4
 
2010
   
12.0
   
1.7
 
2011
   
13.9
   
1.9
 
2012-2016
   
96.7
   
14.7
 

The expected contribution to be paid during fiscal year 2007 is $7.8 million.

-24-

 
Supplementary Financial Information
Included in the Consolidated Balance Sheets captions are the following assets
and liabilities (In Millions):

   
2006
 
2005
 
Accounts receivable -
             
Accounts receivable
 
$
2,120.0
 
$
1,441.6
 
Allowance for doubtful accounts
   
(57.3
)
 
(45.3
)
   
$
2,062.7
 
$
1,396.3
 
Accrued expenses and other liabilities -
             
Accrued salaries
 
$
598.2
 
$
516.6
 
Taxes other than income taxes
   
279.3
   
261.7
 
Profit sharing
   
164.8
   
143.4
 
Other
   
671.0
   
570.2
     
$
1,713.3
 
$
1,491.9
 

 
Summary of Quarterly Results (Unaudited)
(Dollars in Millions, except per share amounts)

   
Quarter Ended
         
November
 
February
 
May
 
August
 
Fiscal Year
 
Fiscal 2006
                               
Net sales
 
$
10,900.4
 
$
12,163.1
 
$
12,175.2
 
$
12,170.3
 
$
47,409.0
 
Gross profit
   
3,002.5
   
3,459.3
   
3,343.2
   
3,363.6
   
13,168.6
 
Net earnings
   
345.6
   
523.5
   
469.2
   
412.3
   
1,750.6
 
Per Common Share -
                               
Basic
 
$
.34
 
$
.52
 
$
.46
 
$
.41
 
$
1.73
 
Diluted
   
.34
   
.51
   
.46
   
.41
   
1.72
 
Fiscal 2005
                               
Net sales
 
$
9,889.1
 
$
10,987.0
 
$
10,830.6
 
$
10,494.9
 
$
42,201.6
 
Gross profit
   
2,707.9
   
3,130.6
   
3,016.2
   
2,933.1
   
11,787.8
 
Net earnings
   
328.6
   
490.9
   
411.0
   
329.0
   
1,559.5
 
Per Common Share -
                               
Basic
 
$
.32
 
$
.48
 
$
.41
 
$
.32
 
$
1.53
 
Diluted
   
.32
   
.48
   
.40
   
.32
   
1.52
 

Comments on Quarterly Results: In further explanation of and supplemental to the
quarterly results, the 2006 fourth quarter LIFO adjustment was a charge of $26.1
million compared to a 2005 credit of $2.0 million. If the 2006 interim results
were adjusted to reflect the actual inventory inflation rates and inventory
levels as computed at August 31, 2006, earnings per share would not have
changed. Similar adjustments in 2005 would have increased earnings per share in
the second quarter by $.01 and decreased earnings per share in the fourth
quarter by $.01.

The quarter ended August 31, 2005, includes $54.7 million ($.033 per share,
diluted) of pre-tax expenses related to Hurricane Katrina.

Common Stock Prices
Below is the Consolidated Transaction Reporting System high and low sales price
for each quarter of fiscal 2006 and 2005.

       
Quarter Ended
             
November
 
February
 
May
 
August
 
Fiscal Year
 
Fiscal 2006
   
High
 
$
48.25
 
$
47.05
 
$
46.07
 
$
50.00
 
$
50.00
 
 
    Low     
40.98
   
42.13
   
39.55
   
40.45
   
39.55
 
Fiscal 2005
   
High
 
$
39.51
 
$
44.19
 
$
46.75
 
$
49.01
 
$
49.01
 
 
    Low     
35.05
   
38.11
   
41.51
   
44.00
   
35.05
 

 

-25-

Management's Report on Internal Control

Our management is responsible for establishing and maintaining adequate internal
control over financial reporting, as such term is defined in Exchange Act Rule
13a-15(f). Under the supervision and with the participation of our management,
including our principal executive officer and principal financial officer, we
conducted an evaluation of the effectiveness of our internal control over
financial reporting based on the framework in Internal Control - Integrated
Framework issued by the Committee of Sponsoring Organizations of the Treadway
Commission (COSO). Based on our evaluation, management concluded that our
internal control over financial reporting was effective as of August 31, 2006.
Our management's assessment of the effectiveness of our internal control over
financial reporting as of August 31, 2006, has been audited by Deloitte & Touche
LLP, an independent registered public accounting firm, as stated in its report
which is included herein.

/s/
Jeffrey A. Rein
/s/
William M. Rudolphsen
 
President and Chief Executive Officer
 
Senior Vice President and Chief Financial Officer

 

-26-

 
REPORT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
 
 
To the Board of Directors and Shareholders of Walgreen Co.:
 
We have audited the accompanying consolidated balance sheets of Walgreen Co. and
Subsidiaries (the åCompanyæ) as of August 31, 2006 and 2005, and the related
consolidated statements of earnings, shareholders' equity, and cash flows for
each of the three years in the period ended August 31, 2006.  These financial
statements are the responsibility of the Company's management.  Our
responsibility is to express an opinion on these financial statements based on
our audits.
 
We conducted our audits in accordance with the standards of the Public Company
Accounting Oversight Board (United States).  Those standards require that we
plan and perform the audit to obtain reasonable assurance about whether the
financial statements are free of material misstatement.  An audit includes
examining, on a test basis, evidence supporting the amounts and disclosures in
the financial statements.  An audit also includes assessing the accounting
principles used and significant estimates made by management, as well as
evaluating the overall financial statement presentation.  We believe that our
audits provide a reasonable basis for our opinion.
 
In our opinion, such consolidated financial statements present fairly, in all
material respects, the financial position of Walgreen Co. and Subsidiaries as of
August 31, 2006 and 2005, and the results of their operations and their cash
flows for each of the three years in the period ended August 31, 2006, in
conformity with accounting principles generally accepted in the United States of
America. 
 
As discussed in "Summary of Major Accounting Policies" in the consolidated
financial statements, effective September 1, 2005, the Company changed its
method of accounting for share-based payments to adopt Statement of Financial
Accounting Standards No. 123(R), Share-Based Payment.
 
We have also audited, in accordance with the standards of the Public Company
Accounting Oversight Board (United States), the effectiveness of the Company's
internal control over financial reporting as of August 31, 2006, based on the
criteria established in Internal Control—Integrated Framework issued by the
Committee of Sponsoring Organizations of the Treadway Commission and our report
dated October 31, 2006 expressed an unqualified opinion on management's
assessment of the effectiveness of the Company's internal control over financial
reporting and an unqualified opinion on the effectiveness of the Company's
internal control over financial reporting.
 
 

 

/s/ DELOITTE & TOUCHE LLP
Chicago, Illinois
October 31, 2006

 

-27-

 
REPORT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
 
 
To the Board of Directors and Shareholders of Walgreen Co.:
 
We have audited management's assessment, included in the accompanying
Management’s Report on Internal Control, that Walgreen Co. and Subsidiaries (the
åCompanyæ) maintained effective internal control over financial reporting as of
August 31, 2006, based on criteria established in Internal Control—Integrated
Framework issued by the Committee of Sponsoring Organizations of the Treadway
Commission.  The Company's management is responsible for maintaining effective
internal control over financial reporting and for its assessment of the
effectiveness of internal control over financial reporting.  Our responsibility
is to express an opinion on management's assessment and an opinion on the
effectiveness of the Company's internal control over financial reporting based
on our audit.
 
We conducted our audit in accordance with the standards of the Public Company
Accounting Oversight Board (United States).  Those standards require that we
plan and perform the audit to obtain reasonable assurance about whether
effective internal control over financial reporting was maintained in all
material respects.  Our audit included obtaining an understanding of internal
control over financial reporting, evaluating management's assessment, testing
and evaluating the design and operating effectiveness of internal control, and
performing such other procedures as we considered necessary in the
circumstances.  We believe that our audit provides a reasonable basis for our
opinions.
 
A company's internal control over financial reporting is a process designed by,
or under the supervision of, the company's principal executive and principal
financial officers, or persons performing similar functions, and effected by the
company's board of directors, management, and other personnel to provide
reasonable assurance regarding the reliability of financial reporting and the
preparation of financial statements for external purposes in accordance with
generally accepted accounting principles.  A company's internal control over
financial reporting includes those policies and procedures that (1) pertain to
the maintenance of records that, in reasonable detail, accurately and fairly
reflect the transactions and dispositions of the assets of the company; (2)
provide reasonable assurance that transactions are recorded as necessary to
permit preparation of financial statements in accordance with generally accepted
accounting principles, and that receipts and expenditures of the company are
being made only in accordance with authorizations of management and directors of
the company; and (3) provide reasonable assurance regarding prevention or timely
detection of unauthorized acquisition, use, or disposition of the company's
assets that could have a material effect on the financial statements.
 
Because of the inherent limitations of internal control over financial
reporting, including the possibility of collusion or improper management
override of controls, material misstatements due to error or fraud may not be
prevented or detected on a timely basis.  Also, projections of any evaluation of
the effectiveness of the internal control over financial reporting to future
periods are subject to the risk that the controls may become inadequate because
of changes in conditions, or that the degree of compliance with the policies or
procedures may deteriorate.
 
In our opinion, management's assessment that the Company maintained effective
internal control over financial reporting as of August 31, 2006, is fairly
stated, in all material respects, based on the criteria established in Internal
Control—Integrated Framework issued by the Committee of Sponsoring Organizations
of the Treadway Commission.  Also in our opinion, the Company maintained, in all
material respects, effective internal control over financial reporting as of
August 31, 2006, based on the criteria established in Internal
Control—Integrated Framework issued by the Committee of Sponsoring Organizations
of the Treadway Commission.
 
We have also audited, in accordance with the standards of the Public Company
Accounting Oversight Board (United States), the consolidated financial
statements as of and for the year ended August 31, 2006 of the Company and our
report dated October 31, 2006 expressed an unqualified opinion on those
financial statements and included an explanatory paragraph relating to the
Company’s change effective September 1, 2005, in its method of accounting for
share-based payments.
 
 

/s/ DELOITTE & TOUCHE LLP
Chicago, Illinois
October 31, 2006

 

-28-

WALGREENS ACROSS THE COUNTRY
     
STATE
2006
2005
Alabama
56
46
Arizona
229
219
Arkansas
36
28
California
438
408
Colorado
113
101
Connecticut
59
52
Delaware
59
-
Florida
697
658
Georgia
111
96
Idaho
17
17
Illinois
511
491
Indiana
167
155
Iowa
55
54
Kansas
50
47
Kentucky
65
59
Louisiana
99
102
Maryland
31
18
Massachusetts
111
106
Michigan
174
165
Minnesota
103
98
Mississippi
41
37
Missouri
152
144
Montana
2
2
Nebraska
43
43
Nevada
59
55
New Hampshire
14
11
New Jersey
90
82
New Mexico
53
52
New York
84
69
North Carolina
91
75
North Dakota
1
1
Ohio
198
173
Oklahoma
75
69
Oregon
44
37
Pennsylvania
65
43
Rhode Island
16
16
South Carolina
52
42
South Dakota
9
6
Tennessee
199
181
Texas
550
516
Utah
27
24
Vermont
2
2
Virginia
56
54
Washington
95
90
West Virginia
1
-
Wisconsin
185
173
Wyoming
7
5
Puerto Rico
69
63
Total*
5,461
4,985

*The total number of stores includes mail service facilities, home care
facilities, clinic pharmacies and specialty pharmacies.